Answer
Women of childbearing potential should use effective contraception during Perjeta (pertuzumab) treatment and for 6 months after the last dose.
Sources for this answer
- Perjeta 420 mg Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 22Document updated
Sources checked